Mar 2, 2026 08:40AM
Mar 2, 2026 08:04AM
Mar 2, 2026 08:00AM
Feb 23, 2026 08:00AM
Nov 6, 2025 08:21AM
Nov 6, 2025 08:00AM
Oct 30, 2025 08:00AM UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
Aug 11, 2025 06:39AM
Aug 8, 2025 08:33AM
Aug 7, 2025 08:16AM
Aug 7, 2025 08:00AM
Jul 29, 2025 08:00AM
May 12, 2025 08:02AM
May 12, 2025 08:00AM UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update
May 1, 2025 04:00PM
Mar 11, 2025 06:42AM
Mar 10, 2025 08:03AM
Mar 10, 2025 08:00AM
Feb 27, 2025 08:00AM
Nov 6, 2024 08:03AM
Nov 6, 2024 08:00AM UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025
Oct 30, 2024 08:00AM
Aug 13, 2024 08:02AM
Aug 13, 2024 08:00AM
Aug 5, 2024 08:00AM
Jul 23, 2024 09:19AM
May 13, 2024 08:04AM
May 13, 2024 08:00AM UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
May 3, 2024 08:00AM
Mar 14, 2024 08:03AM
Mar 14, 2024 08:00AM
Mar 4, 2024 08:00AM
Nov 14, 2023 08:01AM
Nov 14, 2023 08:00AM
Nov 7, 2023 08:00AM UroGen Pharma to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
Aug 10, 2023 08:03AM
Aug 10, 2023 08:00AM
Aug 2, 2023 05:00PM
May 11, 2023 08:25AM
May 11, 2023 08:00AM
May 4, 2023 08:00AM
Mar 16, 2023 08:08AM UroGen Pharma (URGN) Misses Q4 EPS by 15c
Mar 16, 2023 08:00AM
Mar 9, 2023 04:00PM
Nov 10, 2022 08:09AM
Nov 10, 2022 08:00AM
Nov 3, 2022 08:00AM
Aug 11, 2022 08:08AM
Aug 11, 2022 08:00AM UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
Jul 27, 2022 08:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All